These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3953145)

  • 21. The development of NK cell activity in thymectomized bone marrow chimaeras.
    Sihvola M; Hurme M
    Immunology; 1984 Sep; 53(1):17-22. PubMed ID: 6147307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells generated from bone marrow culture.
    Koo GC; Peppard JR; Mark WH
    J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC; Reynolds CW; Herberman RB
    Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
    Weiss L; Reich S; Mandelboim O; Slavin S
    Bone Marrow Transplant; 2004 Jun; 33(11):1137-41. PubMed ID: 15077128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential natural killer cell reactivity against T cell lymphomas by cells from normal or stimulated mice.
    Tai A; Burton RC; Warner NL
    J Immunol; 1980 Apr; 124(4):1705-11. PubMed ID: 6965957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface antigens of murine hemopoietic stem cells. II. Rosetting method used to compare the cross-reactivity of antisera against mouse brain, sperm, and testis cells with bone marrow stem cells and progenitor cells.
    Berridge MV; Okech N
    J Immunol; 1980 Feb; 124(2):732-8. PubMed ID: 6965388
    [No Abstract]   [Full Text] [Related]  

  • 27. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
    Kung SK; Miller RG
    J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts.
    Wu MF; Raulet DH
    J Immunol; 1997 Feb; 158(4):1628-33. PubMed ID: 9029098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of glycosphingolipids on the activity of natural killer cells].
    Diatlovitskaia EV; Sinitsyna EV; Lemenovskaia AF; Bergel'son LD
    Biokhimiia; 1984 Mar; 49(3):432-6. PubMed ID: 6609724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allorecognition by murine natural killer cells: studies with bone marrow transplants and lysis of T lymphoblasts.
    Liu J; Yu YY; Lindahl KF; Kumar V; Bennett M
    Chem Immunol; 1996; 64():164-80. PubMed ID: 8942079
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells.
    Wright SC; Hiserodt JC; Bonavida B
    Transplant Proc; 1981 Mar; 13(1 Pt 2):770-3. PubMed ID: 7268895
    [No Abstract]   [Full Text] [Related]  

  • 36. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors.
    Riccardi C; Barlozzari T; Santoni A; Herberman RB; Cesarini C
    J Immunol; 1981 Apr; 126(4):1284-9. PubMed ID: 7204966
    [No Abstract]   [Full Text] [Related]  

  • 39. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.
    Kuribayashi K; Gillis S; Kern DE; Henney CS
    J Immunol; 1981 Jun; 126(6):2321-7. PubMed ID: 6164729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.